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Generation of de novo cardiomyocytes through viral over-expression of key transcription factors repre-
sents a highly promising strategy for cardiac muscle tissue regeneration. Although the feasibility of cell
reprogramming has been proven possible both in vitro and in vivo, the efﬁciency of the process remains
extremely low. Here, we report a chemical-free technique in which topographical cues, more speciﬁcally
parallel microgrooves, enhance the directed differentiation of cardiac progenitors into cardiomyocyte-
like cells. Using a lentivirus-mediated direct reprogramming strategy for expression of Myocardin,
Tbx5, and Mef2c, we showed that the microgrooved substrate provokes an increase in histone H3
acetylation (AcH3), known to be a permissive environment for reprogramming by “stemness” factors, as
well as stimulation of myocardin sumoylation, a post-translational modiﬁcation essential to the tran-
scriptional function of this key co-activator. These biochemical effects mimicked those of a pharmaco-
logical histone deacetylase inhibitor, valproic acid (VPA), and like VPA markedly augmented the
expression of cardiomyocyte-speciﬁc proteins by the genetically engineered cells. No instructive effect
was seen in cells unresponsive to VPA. In addition, the anisotropy resulting from parallel microgrooves
induced cellular alignment, mimicking the native ventricular myocardium and augmenting sarcomere
organization.
© 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
The adult mammalian heart is one of the least regenerative or-
gans in the body with a very limited innate regenerative response
[1,2]. As a consequence, loss of cardiac muscle caused by ischemic
injury (myocardial infarction) largely outmatches the heart's self-
renewal capacity to create new cardiomyocytes [3]. The resulting
cardiomyocyte deﬁcit, on the order of one billion cells [3],
dramatically impairs cardiac pump function and eventually leads to
heart failure. With a poor prognosis at 5 years, heart failure is todays, Imperial College London,
nslational and Experimental
M.D. Schneider), m.stevens@
r Ltd. This is an open access articleone of the leading causes of morbidity and mortality in the world.
For these precise reasons, generating de novo cardiomyocytes to
replace the lost ones is of high importance.
Various strategies using cell therapy have been considered to
regenerate the myocardium [2,4] including using either: (a)
endogenous cells such as bonemarrow or hematopoietic stem cells,
or (b) exogenous stem or progenitor cells such as embryonic stem
cells [5]. Among the wide range of cell types tested, adult resident
cardiac progenitors hold a particular attraction because they are
present in the heart already, and hold the further advantage of
having an intrinsic predisposition to differentiate into the cardiac
muscle lineage, ascribed to their expression of diverse cardiac
transcription factors [6e10].
The ground-breaking work by Yamanaka and colleagues using
four genetic factors (Oct4, Klf4, Sox2, c-Myc) to reprogram somatic
cells into induced pluripotent stem cells (iPSCs) resembling em-
bryonic stem cells prompted the use of analogous cocktails to
reprogram adult cells forward, instead, into lineage-speciﬁcunder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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ming strategies, direct trans-differentiation to the cardiac muscle
cell lineage by over-expression of key transcription factors has
shown great promise for cardiac repair [12]. Both in vitro and
in vivo, various cocktails have been reported to show the conversion
of somatic cells directly towards a cardiomyocyte fate [13e27].
Although this ﬁnding was challenged in its early days [28], many
recent papers have validated the rationale underlying this meth-
odology in both human and mouse [12]. Notably, however, no
single cocktail or reprogramming strategy has yet become a gold
standard for conversion of somatic cells to cardiomyocyte-like cells.
The efﬁciency remains extremely low, and the maturation of the
induced cardiac muscle cells incomplete and elusive in culture,
although higher degrees of organisationmay occur after adaptation
to the cardiac milieu [20].
Resistance to reprogramming is known to be attributable in
large part to a cell's epigenetic characteristics [29,30]. By stabilising
one cell type, epigenetic factors control a cell's fate. Conversely,
chromatin remodelling enzyme inhibitors such as valproic acid
(VPA) have been widely reported to enhance cellular reprogram-
ming dramatically, signiﬁcantly improving the conversion efﬁ-
ciency and sometimes even supplanting some reprogramming
factors [31]. A similar approach has been suggested for conversion
to the cardiac muscle fate [18,32,33].
One of the main challenges in the ﬁeld of tissue engineering re-
sides in ﬁnding the optimal cellularmicro-environment bywhich to
control cell fate and enhance maturation [34e37]. For cardiac
muscle, inducing artiﬁcial alignment through ad hoc topographical
factors or manipulating the substrate stiffness [38,39] has been
shown to greatly improve sarcomere organisation and calcium
cycling in various stem cell-derived cardiomyocytes [40e42].
Interestingly, the use of various biophysical cues has also been
recently reported as an efﬁcient strategy to inﬂuence chromatin
remodelling and improve cellular reprogramming,working through
a substrate-induced decrease in histone acetylation and mimicking
the epigenetic effect of histone deacetylase inhibitors [43e45].
As a result, we address in this work the question of whether
topographical cues (parallel microgrooves) in combination with a
forward reprogramming strategy (a cocktail of three cardiogenic
transcription factors) could positively affect de novo generation and
maturation of cardiomyocytes from adult heart-derived progenitor
cells. Speciﬁcally, based on the prior work cited [18,43], we hy-
pothesized that microgrooves would likewise enhance forward
programming, requiring two preconditions: that histone acetyla-
tion was in fact enhanced by grooves in the precursor cells tested,
and that the cells furthermore were responsive to a pharmacolog-
ical HDAC inhibitor. The predicted phenotype was seen in cells
fulﬁlling these criteria and not in cells lacking them.
2. Materials and methods
2.1. Cell culture and reprogramming
Clones were generated as previously described [46,47] and
maintained in clonal growth medium (CGM) comprising 65% (v/v)
Dulbecco's Modiﬁed Eagle's Medium/Ham F-12 (Life Technologies),
35% (v/v) Iscove's Modiﬁed Dulbecco's Medium (IMDM; Life Tech-
nologies), 3.5% (v/v) bovine growth serum (Thermo Scientiﬁc),
100 U/mL Antibiotics-Antimycotics (Life Technologies), 2 mM L-
glutamine (Life Technologies), 0.1 mM b-mercaptoethanol (Sigma),
1.3% (v/v) B27 media supplement (Life Technologies), 6.5 ng/mL
EGF (Petrotech), 13 ng/mL FGF (Petrotech), 0.0005 U/mL thrombin
(Roche), 0.345 ng/mL cardiotrophin-1 (Cell Science). For reprog-
ramming experiments we used a previously described protocol
[46]. Brieﬂy cells were ﬁrst transduced with a lentiviral rtTA-IRES-Puro vector and subsequently selected with puromycin (Life Tech-
nologies) for 14 days. Cells were then transduced with the tran-
scription factor-encoding lentiviral vectors: TRE-Myocd-ING, TRE-
Tbx5-INR (kindly obtained from Lei Zhou, Texas Heart Institute,
Houston, Texas, USA) [48] and TRE-Mef2c-ING (cDNA from BioSci-
ence LifeSciences cloned onto the Myocardin lentiviral backbone
[46]). One day following transfection, CGM was changed for IMDM
supplemented with 10% (v/v) bovine growth serum, 100 U/mL
Antibiotics-Antimycotics, 2 mM L-glutamine, 0.1 mM b-mercap-
toethanol and 1 mg/mL doxycycline (Sigma) and medium changed
every 48 h for the duration of the reprogramming experiment.
When cells were treated with valproic acid (Sigma) a 0.5 mM
concentration was systematically used.
2.2. Membrane fabrication
Silicon wafers patterned with microgrooves (10 mm wide, 3 mm
deep) using standard soft-lithography techniques. Brieﬂy, photo-
resist (SU8-2002) was spin-coated (z250 mm) onto a silicon wafer
and a patterned photomask was used to expose the photoresist to
UV light. The un-polymerized photoresist was subsequently
washed away. Polydimethylsiloxane (PDMS) was then prepared
according to manufacturer's protocol (Sylgard 184, Dow Corning),
degassed under vacuum, spin-coated onto the patterned silicon
wafers and cured at 110 C for 40 min. The resulting micro-
patterned membranes were removed from the template, thor-
oughly washed and plasma treated prior to UV sterilization and
collagen I coating (rat tail, Life Technologies).
2.3. Scanning electron microscopy
Cells cultured on PDMS membranes were ﬁxed with 3.7% (v/v)
formaldehyde in PBS for 15min, and then dehydrated bywashing for
5min inprogressivelyhigherconcentrationsof ethanol inwater (30%,
50%, 70%, 90%, 100%x2) followed by two washes in hexamethyldisi-
lazane for 5min. A 10 nm thinﬁlmof Crwas deposited on the sample
by sputter coating, to prevent charging. The sample was analysed at
10 KeV in a LEO 1525 FEGSEMwith a secondary electron detector.
2.4. Edu incorporation assay
Cells were pulsedwith 10 mMEdU (Invitrogen) for 2 h a day after
being seeded on the various substrates. Cells were subsequently
ﬁxed with 4% paraformaldehyde and permeabilized in 0.2% (v/v)
Triton X-100 before incubation with Click-iT reaction cocktail
(Invitrogen). 40,6-diamidino-2-phenylindole (DAPI) was used for
nuclear staining, analysis was then performed with conventional
epiﬂuorescence microscopy.
2.5. Immunoﬂuorescence, imaging and quantiﬁcation
Cells were ﬁxed in 3.7% (v/v) paraformaldehyde for 10 min, then
permeabilized and blocked in PBS with 4% (v/v) bovine growth
serum (Thermo Scientiﬁc) and 0.2% (v/v) Triton X-100 for 1 h, and
subsequently incubated with primary antibodies for AcH3 (Milli-
pore), Actc1 (Sigma), sarcomeric MyHC (R&D), Nppa (Millipore),
Ryr2 (Sigma), Pln (Abcam) in blocking buffer overnight on a rocker
at 4 C. Secondary antibody incubation (Alexa 647, Life Technolo-
gies) was performed in blocking buffer for 1 h at room temperature.
The ﬁxed PDMS membranes were then mounted on slides in Vec-
tashield® mounting medium and analysed with confocal micro-
cospy (Zeiss LSM-780 inverted) or conventional epiﬂuoresence
microscopy with a Zeiss Axio-Observer Z1 wideﬁeld ﬂuorescent
microscope.
High-throughput image analysis was performed with a custom
C. Morez et al. / Biomaterials 70 (2015) 94e10496made Matlab® script. Brieﬂy, cell nuclei were detected using
contrast enhancement methods, then segmented with an edge
detection algorithm (Canny; Matlab®), following which elliptical
ﬁtting was performed to compute the aspect ratio (short axis/long
axis) and the angle between the long axis and the groove direction.Fig. 1. Cell and nuclear elongation in cloned cardiac stem cells on the microgrooved sub
SP16 cells cultured for 3 days on ﬂat and patterned substrates (scale bar: 200 mm). (B) Scan
(scale bar: 20 mm). (C) EdU incorporation analysis showing decreased clone SP16 proliferati
showing the nuclear elongation (aspect ratio of nuclei elliptical ﬁtting) as a function of ea
patterned substrates align within 10 parallel to the grooves and are signiﬁcantly more el
interpretation of the references to colour in this ﬁgure legend, the reader is referred to the2.6. Protein extraction, immunoprecipitation and Western blotting
Cells on each membrane were lysed on ice with RIPA lysis buffer
supplemented with PMSF in DMSO, a protease inhibitor cocktail in
DMSO and sodium orthovanadate in water (Santa Cruz). Protein
lysates were centrifuged to pellet cellular debris, and thestrate. (A) Cytoskeletal actin (Phalloidin, green), and nuclear (DAPI, blue) staining of
ning electron microscopy of SP16 cells (cyan, pseudocolour) aligned along the grooves
on on grooves (n ¼ 3, p < 0.05, error bars indicate standard deviation). (D) Scatter plot
ch cell's alignment along the grooves (angle between long axis and grooves). Cells on
ongated, 0.49 ± 0.14 on the microgrooved surface versus 0.71 ± 0.12 (p < 105). (For
web version of this article.)
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(Bio-Rad). Protein samples were run in SDS/PAGE and transferred to
nitrocellulose membranes. Membranes were blocked with 3% non-
fat milk and incubated with the primary antibodies (AcH3, Milli-
pore; GAPDH, Santa Cruz) diluted in TBST (Tris-Buffered Saline
Tween-20) buffer containing 25 mM TrisHCl (pH 7.4), 60 mM NaCl,
and 0.05% (v/v) Tween-20 overnight. Infrared secondary antibody
(LI-COR) incubation was then performed at room temperature for
1 h before analysis with an Odyssey Imager system (LI-COR). For
immunoprecipitation studies, 20 mN NEM (Sigma) was supple-
mented to the RIPA lysis buffer with the previously mentioned
cocktail of inhibitors. Cellular lysates were pre-cleared with protein
A agarose (Santa Cruz), before a 10% input was removed and the
remaining lysate incubated with SUMO-1 antibody-agarose con-
jugated beads (Santa Cruz). The pellet was collected and exten-
sively washed in lysis buffer before being analysed by Western
blotting with anti-myocardin antibody (Abcam).
2.7. RNA isolation and qRT-PCR
Cells were lysed using TRIzol®, and RNA subsequently extracted
and puriﬁed using the PureLink RNA minikit (Life Technologies).
RNA concentration and purity was determined with a Thermo
Scientiﬁc Nanodrop spectrophotometer.
cDNA was then reverse transcribed from RNA using the High-
capacity cDNA Reverse Transcription Kit (Applied Biosystems).
qRT-PCR were performed using custom 384-well microﬂuidic
cards (Taqman low density array cards, Life Technologies) and an
ABI PRISM 7900HT Sequence Detection System (Applied Bio-
systems). Data analysis was performed using DataAssist™ Software
v3.01 (Applied Biosystems).
2.8. Statistical analysis
All statistical tests were performed with the Excel Data AnalysisFig. 2. qRT-PCR heat map for genes including cardiogenic transcription factors and cardiac, s
an unsupervised complete-linkage method for Euclidean distance. SP3, SP16, mouse heart a
expression were evoked by growth on ﬂat versus patterned (≡) membranes.Toolpak (2010). All results are expressed as the mean ± standard
deviation (SD). To test signiﬁcance, one-way ANOVA was per-
formed. To compare the differences between microgrooved mem-
brane samples and ﬂat membrane samples, we used the unpaired
two-tails Student's t-test. Results for which p < 0.05 were consid-
ered statistically signiﬁcant (n  3 in all experiments).
3. Results
3.1. Microgrooved substrates induce cell alignment and nuclear
elongation but no spontaneous differentiation of cloned cardiac side
population (SP) cells
Sca1 positive (Sca1þ) cardiac progenitors have been shown to
have cardiac differentiation potential in vitro and in vivo, and to be a
target for the enhancement of regeneration by prostaglandin E2
[6e8,49]. Further studies have demonstrated that a subpopulation
identiﬁed by the extrusion of Hoechst dye 33342, the so-called side
population (SP), are enriched for clonal growth and account for
cardiac differentiation capacity [50,51]. Thus, we used two clonally
derived hematopoietic lineage-negative (Lin-), Sca1þ, SP resident
adult progenitor cell lines [51]. Each represents the progeny derived
from an independent single cell deposited by ﬂuorescence-
activated cell sorting (FACS). We chose to use clonal derivatives to
remove the heterogeneous element intrinsic to the population of
Sca1þ progenitors.
Two speciﬁc SP clones were selected, clones 3 and 16, hereafter
referred as SP3 and SP16 respectively. SP3 and SP16 clones
resemble an incomplete form of cardiac mesoderm as shown by
expression of several key cardiac transcription factors (such as
Gata4/6, Hand2, T-box factors, and Mef2a) but the absence of car-
diomyocyte differentiation markers (such as sarcomeric gene
expression) [51]. Though sharing this general signature, the cloned
SP cells possess microheterogeneities of cardiac transcription factor
expression [51]. Notwithstanding these differences and themooth muscle, and endothelial differentiation markers. Clustering was performed using
nd bone marrow controls were well resolved. No signiﬁcant changes in baseline gene
C. Morez et al. / Biomaterials 70 (2015) 94e10498transcription factors absent from the cells, both clones exhibit
multi-lineage differentiation into cardiac muscle, vascular smooth
muscle, and endothelial cells after delivery to healthy or infarcted
myocardium [51]. By contrast, no spontaneous differentiation
in vitrowas observed (data not shown), suggesting that in vivo cues,
potentially including physical ones, are essential to relieve their
differentiation arrest following cell grafting.
The SP cells were maintained on standard tissue culture plates
with collagen I coating prior to being seeded on collagen I coated
polydimethylsiloxane (PDMS) membranes (Young's modulus of the
order of 1 MPa) that were either ﬂat or microgrooved (10 mmwide,
3 mm deep) and fabricated using standard soft-lithographyFig. 3. Histone 3 acetylation (AcH3) on the microgrooved substrate. (A) Western blot sho
immunostaining for AcH3 (scale bar: 20 mm). (C) Scatter plot showing AcH3 levels (immuno
for both clones on ﬂat surface versus grooves. As cells' nuclei become more elongated, AcH
evoked in clone 3.techniques. As expected from results in other cell types [52,53],
cloned cardiac SP cells adopted a very elongatedmorphology on the
patterned substrates as shown by cytoskeletal staining (Fig. 1A and
Suppl. 1A) and scanning electron microscopy (Fig. 1B), sitting either
on top of the microgrooves or falling into the ridges between the
grooves. Cell proliferation, quantiﬁed by incorporation of 5-
ethynyl-2’-deoxyuridine (EdU), was decreased by one-fourth on
the microgrooved substrate (from 32% to 24%; Fig. 1C and Suppl1C),
corroborating previous ﬁndings obtained in ﬁbroblasts [43] or
vascular stem cells [54]. Accordingly to a study positively corre-
lating nuclear volume and DNA synthesis [55], nuclear volume on
grooved substrates was signiﬁcantly reduced (Fig. Suppl. 2).wing the AcH3 levels on the microgrooved versus ﬂat substrate. (B) Representative
staining) as a function of the nuclear elongation (aspect ratio of nuclei elliptical ﬁtting)
3 levels increase on the patterned substrate in clone 16, while no further acetylation is
C. Morez et al. / Biomaterials 70 (2015) 94e104 99Notably, patterned substrates induced a dramatic nuclear elonga-
tion of both SP3 and SP16 cells (Fig. 1D and Suppl. 1B), with the
average length of a cell nucleus on the grooves being twice as long
as it was wide.Fig. 4. De novo cardiomyocyte generation (A) Schematic of the reprogramming process. (B
factors, sarcomeric proteins and calcium handling proteins (* indicates signiﬁcance for pair
**p < 0.01, *p < 0.05, n ¼ 3, error bars indicate standard deviation). (C,F) Fluorescence micros
muscle markers (scale bar: 20 mm). (D,G) Quantiﬁcation of immunostaining results (***p < 0.To assess the differentiation potential that results from culturing
cells on the microgrooved topography, we compared the cells'
phenotype after 5 days on the respective substrates. We used
quantitative real-time polymerase chain reaction (qRT-PCR) to,E) qRT-PCR results showing the induction of cardiac markers including transcription
-wise a comparison Student's t-test against the ﬂat doxycycline controls, ***p < 0.001,
copy showing reprogrammed cells on the ﬂat surfaces positive for the indicated cardiac
001, **p < 0.01, *p < 0.05; Student's t-test, n ¼ 6, error bars indicate standard deviation).
C. Morez et al. / Biomaterials 70 (2015) 94e104100examine the expression of the indicated genes (Fig. 2), including
cardiogenic transcription factors (Gata4, Gata6, Hand1, Hand2,
Mef2a, Mef2c, Nkx2.5, Tbx5, Tbx20, Isl1) and representatives of the
differentiated cardiac (Actc1, Myh6, Pln, Ryr2), endothelial (Cdh5),
and smooth muscle (Myh11) lineages. Cardiac transcription factors
and structural genes were readily detected in the adult heart
(excepting Isl1, in keeping with its known developmental regula-
tion) but largely absent in bone marrow as expected. The progen-
itor cells lack expression of cardiac or vascular structural genes but
express many cardiac transcription factors suggesting they are
transcriptionally predisposed to cardiac lineage differentiation but
are still in an undifferentiated state. The two clones express
different sets and levels of cardiac transcription factors, similar to
the microheterogeneities within freshly isolated cardiac progenitor
cells [51]. No genetic marker was differentially expressed more
than 2-fold between ﬂat and patterned substrates (Fig. 2). In
addition, cells failed to segregate based on their culture substrate
following 2-dimensional unsupervised clustering of the qPCR re-
sults (Fig. 2). Thus, no large spontaneous phenotypic changes were
detected from short-term culture on a microgrooved substrate: the
cell phenotype was maintained similar to that previously seen in
standard cell culture conditions for these clones.Fig. 5. Effect of VPA-induced histone hyper-acetylation on cardiac reprogramming. (A) Sarc M
ﬂat substrate without VPA (***p < 0.001, **p < 0.01, *p < 0.05; Student's t-test against the ﬂa
increase in AcH3 following incubation for 24 h with 0.5 mM VPA.3.2. Histone acetylation on grooves is cell dependent and associated
with nuclear elongation
Topographical cues such as parallel microgrooves have been
previously reported to increase histone 3 acetylation (AcH3) in
mouse ﬁbroblasts and mesenchymal stem cells [43,53,56]. To test
whether cloned cardiac progenitor cells were subject to the same
effects, we performed Western blotting analysis and immunoﬂuo-
rescence microscopy. Interestingly, one of our clones, SP16, un-
derwent an increase in AcH3 while cultured on the micropatterned
substrate (Fig. 3AeB and Suppl. 3C).
By contrast, SP3 AcH3 levels on the un-patterned substrate were
signiﬁcantly higher than those of SP16, similar instead to SP16 cells'
level of AcH3 on microgrooves (Fig. 3AeB and Suppl. 3C). This
suggests that topographically induced hyper-acetylation on
microgrooved substrates is not ubiquitous even within a cell type,
and may depend on the cells' baseline acetylation levels. To
investigate further the role of topography on histone acetylation,
we looked for possible correlations between individual cells' nu-
clear elongation and histone acetylation, analysing thousands of
nuclei with a custom Matlab® script. Strikingly, we found a statis-
tically signiﬁcant direct correlation between the nuclear elongationyHC and Nppa expressed in transduced cells is shown as the fold increase compared to
t control, n ¼ 63, error bars indicate standard deviation). (B) Western Blot showing the
Fig. 6. Myocardin sumoylation on ﬂat and patterned substrates was assessed by
immunoprecipitating cell lysates (INPUT) with anti SUMO-1 conjugated agarose beads
(IP-SUMO). Immunoglobulin heavy (IgH) and light (IgL) chains of the IP antibody are
indicated, GAPDH was used as a loading control. *p < 0.05; Student's t-test against the
ﬂat control, n ¼ 3, error bars indicate standard deviation. Myocardin sumoylation was
enhanced only in the VPA-sensitive cells (cf. Fig. 5).
C. Morez et al. / Biomaterials 70 (2015) 94e104 101of SP16 and levels of AcH3 (Fig. 3C and Suppl. 3A-B, p ¼ 0.018 for a
pair-wise comparison of the slopes between grooved and ﬂat sur-
faces). Although, a priori, nuclear elongation might accompany
increased histone acetylation rather than cause it, this ﬁnding is
noteworthy in light of previous reports directly implicating the
nuclear envelope protein Lamin A/C in the increase of AcH3 levels
on grooved substrates [53], i.e., a nuclear basis for mechano-
transduction in the setting we studied.
3.3. Forward programming toward the cardiomyocyte lineage is 2-
fold higher on microgrooves
Histone acetylation, chromatin compaction and epigenetic sta-
bility are known to be major hurdles faced in reprogramming
strategies [29]. Conversely, chemical inhibitors of speciﬁc histone
remodelling enzymes have been successfully used to facilitate
cellular trans-differentiation by directly affecting the chromatin
state [57]. For example, the histone deacetylase (HDAC) inhibitor
valproic acid (VPA) has been shown to increase direct reprogram-
ming of cardiomyocytes 2-fold (measured as sarcomeric myosin
heavy chain (MyHC) positive cells) by inducing histone hyper-
acetylation [18]. To assess whether our microgrooved substrates
could enhance the generation of de novo cardiomyocytes through a
biophysical regulation of histone acetylation, we infected both our
SP3 and SP16 clones with a tetracycline-inducible lentiviral system,
by which overexpression of a cocktail of cardiogenic transcription
factors was homogeneously transduced but stringently controlled
by doxycycline (Dox; Fig. 4A). Considering previously published
ﬁndings [18,24] and the expression patterns of cardiac transcription
factors in our two SP clones [51], we chose to overexpress Mef2c,
Myocardin and Tbx5. Fifteen days following the addition of Dox we
analysed by qRT-PCR a set of 45 cardiac markers. Among those
examined, a large subset was signiﬁcantly up-regulated compared
to the non-doxycycline control (Fig. 4B and E). These up-regulated
genes comprised structural proteins (Actc1, Myh6, Myl2, Myl3,
Myl4, Myl7, Myom1, Myom2, Tnnc1, Ttn) but also calcium handling
proteins (Casq2, Ryr2), which indicated a cardiomyocyte-like
phenotype or, at least, extensive changes toward that lineage. To
further validate our ﬁndings, we performed immunoﬂuorescent
labelling for cardiac-restricted structural proteins (sarcomeric
MyHC, a-cardiac actin) and calcium handling proteins (ryanodine
receptor, phospholamban). Cells staining positive for those four
markers were systematically found in all reprogramming experi-
ments, using the SP3 or SP16 clones (Fig. 4C and F). Dox-dependent
induction of lineage-restricted sarcomeric proteins and regulators
of calcium handling is strongly supportive of progression toward a
cardiomyocyte phenotype.
To test the predicted synergy between our genetic directed
differentiation procedure and the microtopographical cues, we
counted cells which were positive for the expression of sarcomeric
MyHC, Actc1, and atrial natriuretic peptide (Nppa) concordantly. In
the reprogrammed SP16 cells, we consistently observed twice as
many positive cells (for all three markers) on the patterned sub-
strate, compared to the ﬂat one (Fig. 4D). We emphasize that the
biochemical composition and stiffness of the substrates was iden-
tical, under the conditions tested, with the sole difference being the
absence or presence of a microgrooved surface pattern. By contrast,
consistent with the lack of change in AcH3, no difference was
observed for SP3 cells (Fig. 4G), transduced under identical condi-
tions and exhibiting comparable baseline responses to the exoge-
nous transcription factors. Given this difference, we postulated that
the observed increase in reprogramming efﬁciency conferred by
the patterned substrate is the result of the observed increase in
histone acetylation of clone SP16 on the microgrooves.
To test this hypothesis directly, we repeated the reprogrammingexperiments in the presence or absence of VPA, a histone deace-
tylase inhibitor. In transduced cells prior to the addition of doxy-
cycline, VPA induced a global increase in AcH3 for SP16 yet no
noticeable difference for SP3 (Fig. 5A). Interestingly, upon addition
of doxycycline to induce the exogenous transcription factors, in-
cubationwith VPA enhanced the differentiation of SP16 cells on ﬂat
membranes, as assayed by the numbers of MyHC-positive and
Nppa-positive cells, evoked no further increase in SP16 cells on
microgrooved membranes, and had no effect on SP3 differentiation
on either substrate (Fig. 5B). The inability of VPA to augment the
reprogramming efﬁciency evoked by grooves suggests that the
topographically-induced increased efﬁciency on patterned sub-
strates could be attributable to the increased histone acetylation.
To provide further evidence that increased differentiation on the
microgrooved substrate is related to histone 3 acetylation and a
cell's sensitivity to HDAC inhibition, we assessed the sumoylation of
the cardiac co-activator myocardin, an essential component of our
gene transfer study [46]. In agreement with recent reports of car-
diac proteins' enhanced sumoylation after HDAC inhibition [58], we
observed a signiﬁcant increase of myocardin sumoylation on the
microgrooved substrates, only in our HDAC inhibitor-sensitive
clone SP16 (Fig. 6). Since myocardin sumoylation is proven to
strongly activate cardiogenic gene activity [59], the observed dif-
ferences in myocardin sumoylation provide a highly credible
explanation for the increased differentiation on microgrooved
substrates only in our HDAC inhibitor-sensitive cell population.
3.4. Sarcomere formation is enhanced on the microgrooved
substrate
In addition to the mere up-regulation of cardiomyocyte-speciﬁc
markers at the RNA and protein level, a further critical component
of bona ﬁde cardiac muscle cells is the presence of key structural
attributes such as the formation of sarcomeres [12].
Fig. 7. Sarcomere-like structures provoked by microgrooves. (A) Sarcomere-like structures in reprogrammed SP3 and SP16 cells, comparing grooved versus ﬂat substrates by
confocal imaging for sarc MyHC. Scale bar: 50 mm and insert, 5 mm. (B) Microgrooves induced a 10-fold increase in ordered sarcomeres (*p < 0.05; Student's t-test, n ¼ 63, error bars
indicate standard deviation).
C. Morez et al. / Biomaterials 70 (2015) 94e104102For pluripotent cell-derived cardiomyocytes, which enter the
cardiac lineage in response to developmentally relevant peptide
growth factors, it has been reported that breaking the artiﬁcial
in vitro isotropy characteristic of routine cell culture, by appropriate
topographical cues, enhances the formation of sarcomeres [40]. In
our reprogrammed cells, very few organized sarcomeres could be
identiﬁed on the ﬂat surfaces (Fig. 7A), suggestive of inefﬁcient or at
least incomplete reprogramming. By contrast, we found the sys-
tematic establishment of highly ordered sarcomeres on the
microgrooved substrate (Fig. 7A). Quantiﬁcation of such structures
revealed a 10-fold increase in the number of MyHC-positive cells on
the microgrooved substrate compared to the ﬂat surface (Fig. 7B).
Because sarcomere organization was enhanced equally in both
lines (Fig. 7B), this aspect of the phenotype does not depend on the
different baseline levels of AcH3. Conversely, no differences be-
tween the lines exist in the prevalence of sarcomere order, as a
possible counter-explanation for the increased differentiation of
SP16 cells on microgrooves (Fig. 5B).4. Discussion
Forward reprogramming towards the cardiomyocyte lineage
represents a great promise in the ﬁeld of cardiac regeneration
through the generation of new cardiomyocytes from differentiated
cells [10]. However, low reprogramming efﬁciency along with
imperfect differentiation remains a great challenge to overcome
before forward reprogramming strategies can represent a useful
source of bona ﬁde cardiomyocytes. In our study, we report a novel
technique, using materials engineering coupled with forward
reprogramming to signiﬁcantly improve the generation of de novo
cardiomyocytes from adult cardiac progenitors both in terms of
efﬁciency (Fig. 4D) and maturation (Fig. 7B). More speciﬁcally, we
showed that the concomitant increase in AcH3 and myocardin
sumoylation levels induced by the use of parallel microgrooves as
topographical cues does not occur equally in all cells, yet is highly
uniformwithin clonal derivatives of the starting cardiac progenitor
cell population (Fig. 4). Our results suggest that this stable, clonally
C. Morez et al. / Biomaterials 70 (2015) 94e104 103inherited difference is likely inﬂuenced by the cells' original
intrinsic levels of acetylation (Fig. 4A) and can be assessed by a cell's
sensitivity to HDAC inhibition (Fig. 5). In addition, we showed that
the induced acetylation in susceptible cells was quantitatively
related to the extent of nuclear elongation (Fig. 4C). This observa-
tion underscores the likely critical role of nuclear matrix proteins in
the biophysical regulation of a cell's epigenetic landscape. Future
studies will be of interest to dissect the proteins and pathways
mediating mechanotransduction in this context and its epigenetic
effects.
Although induced acetylation had been shown to increase
reprogramming to iPSCs, allowing the chromatin to be in a state
which more closely resembles that of a pluripotent stem cell
[43,60,61], it was not clear whether the same strategy would
enhance direct programming towards any differentiated lineage. In
this study, we show that induced acetylation indeed can also
improve forward reprogramming (Fig. 5). This result in particular
opens the ﬁeld to a biomaterials approach in other trans-
differentiation strategies where clinical translation is critically
impaired by the low efﬁciency associated with such strategies, and
again emphasises the importance of epigenetic regulation in the
control of cell fate [62]. It will be intriguing in future studies to
determine whether biophysical cues act via the initial recruitment
of exogenous transcription factors to their target sites, perhaps
supplanting the need for pioneer factors that bind to closed chro-
matin, versus one or more other stages in reprogramming. Like-
wise, it will be of interest to dissect the signalling cascade for
nanotopographical cues.
Finally, we demonstrated that in addition to enhancing the
overall number of cardiomyocyte-like cells generated (Fig. 4D), the
use of speciﬁc topographical cues could enhance the maturation of
induced cardiomyocytes by providing guidance and cues that
mimic the in vivo environment (Fig. 7). To our knowledge, this is the
ﬁrst study where a material-based approach has been used to
facilitate cell fate switching through a biophysical regulation a cell's
epigenetic landscape and also to enhance maturation concomi-
tantly, by bringing artiﬁcial alignment reminiscent of natural tissue.
Such a strategy could therefore be used in future biomaterials-
based approaches in tissue engineering as a means to promote
cells differentiation in culture before integration or as part of an
integrable system providing mimetic cues that favour maturation
[63].
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